You are viewing Sub-Saharan Africa

Choose Your Location:
  • United States
  • Canada
  • Latin America
  • EMENA
  • Sub-Saharan Africa
  • Russia
  • South Asia
  • Asia Pacific
  • China
  • Global

Choose Your Location:

usa-noactive usa-active
United States
canada-noactive canada-active
Canada
latin-america-noactive latin-america-active
Latin America
north-america-noactive emena-active
EMENA
Africa Africa
Sub-Saharan Africa
Russia Russia
Russia
South Asia South Asia
South Asia
Asia Asia
Asia Pacific
China China
China
global-site-noactive global-site-active
Global

Articles by Kemin Biologics

Uncover scientific evidence supporting the safety and efficacy of Kemin vaccines as drivers of immune resilience in your operation.

transboundary control

  • Technical Literature #1 Efficacy of MEFLUVACTM H5 PLUS 8 in chickens challenged with HPAI subtypes H5N8 (clade 2.3.4.4b) and H5N6 (clade 2.3.4.4g)
  • Technical Literature #2 Protection granted by different Avian Influenza Virus (AIV) Inactivated vaccines against challenge with H5N8 duck and chicken isolates
  • Technical Literature #3 Assessing the Efficacy of MEFLUVACTM H5 PLUS 8 in chickens challenged with Highly Pathogenic Avian Influenza clade 2.3.4.4.b recently isolated in Peru
  • Technical Literature #4 Assessing the Efficacy of MEFLUVACTM H5 PLUS 8 in Turkeys challenged with Highly Pathogenic Avian Influenza clades 2.2.1.2 and 2.3.4.4.b
  • Technical Literature #5 MEFLUVAC™ H5 PLUS 8 efficacy against HPAI subtypes H5N1 (clade 2.3.2.1c), H5N6 (clades 2.3.4.4g and 2.3.4.4h) and H5N8 (clade 2.3.4.4b)
  • Technical Literature #6 Homologous Antigen in the Hemagglutination Inhibition Assay: A Key Factor to Effectively Monitor Avian Influenza Vaccines in Poultry
  • Technical Literature #7 Assessing the Efficacy of MEFLUVACTM H9N2 inactivated vaccine strain (A/Chicken/Egypt/ME/543V/2016) in association with a bivalent live IB-ND vaccine
  • Technical Literature #8 Serological Response in Layers after Vaccination with the Inactivated Trivalent HPAI vaccine MEFLUVACTM H5 PLUS 8
  • Technical Literature #9 Assessing the Impact of MEFLUVACTM H9-16 in concentrated dose (0.3 mL) to the Vaccination Program of White Broiler Chickens
  • Technical Literature #10 Boosting Immunity in Broilers with MEVACTM ELI VAR 2 (bivalent live NDV VG/GA and IBV VAR 2) and MEFLUVACTM H9ND-16 (bivalent inactivated H9N2 and NDV LaSota) vaccines
  • Technical Literature #11 Addressing the Key Factors influencing the Vaccine Absorption following the administration of MEFLUVACTM Range
  • Technical Literature #12 Antigenic Distance between the Asian circulating Clade 2.3.2.1c and the Trivalent Vaccine MEFLUVAC™ H5 PLUS 8

  • Technical Literature #2 Assessment of the Immune Response and Production Parameters in Dairy Cows after Vaccination with MEVACTM LSD
  • Technical Literature #4 Understanding the Neethling Response: A Side Effect of Live Attenuated Vaccines for Lumpy Skin Disease in Cattle
respiratory integrity

  • Technical Literature #1 Cross protection conferred by the Infectious Bronchitis (IB) Variant 2 vaccine antigen against virulent challenge with IB QX Variant
  • Technical Literature #2 Efficacy of MEVACTM ND ELITE and MEVACTM ND LASOTA comparing several vaccination regimens against challenge with Newcastle Disease Virus GVII
  • Technical Literature #3 Evaluation of the Recombinant Genotype VII.1.1 NDV Vaccine RINNOVACTM ELI-7 in Broiler Chickens - A Technical Review
  • Technical Literature #4 Efficacy and Immunogenicity of RINNOVACTM ELI-7 Vaccine Against Newcastle Disease Virus Genotype VII
  • Technical Literature #5 Immunogenicity of MEVAC™ LASOTA + H120 Live Vaccine in Commercial Layer Pullets under Field Conditions
  • Technical Literature #6 Evaluation of the Safety and Potency of MEVAC™ ND BROILER Vaccine Under Field Conditions
  • Technical Literature #7 Field Evaluation of MEVAC™ ND7 PLUS BROILER: A Bivalent Inactivated Oil Emulsified Vaccine for Immunization against Newcastle Disease GII and GVII
immunocompetence

  • Technical Literature #1 Evaluation of MEVACTM IBD 818 Live Gumboro Vaccine in Broilers under controlled and field conditions: Pathogenicity, Immunogenicity and Performance
  • Technical Literature #2 Efficacy of MEVACTM IBD 818 in chickens challenged with very virulent Infectious Bursal Disease (IBD) strain under controlled conditions
Immune Resilience

  • Technical Literature #1 Standard Diagnostic Procedures for Post-Vaccination Monitoring of Kemin Vaccines: AIV, NDV, IBV

Seeking Superior Poultry Vaccines?

Fill out the form below to connect with a Kemin expert.

The content on this site is intended for informational purposes only and is not intended to be a substitute for professional veterinary advice. Although the information on this site is accessible worldwide, not all products or services are available to all persons or in all geographic locations or jurisdictions. Certain statements, product labeling and claims may differ by geography or as required by local governmental regulations.